Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC (RAD001)

This study has been terminated.
(Poor accrual)
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
University of Chicago
ClinicalTrials.gov Identifier:
NCT01063478
First received: February 3, 2010
Last updated: January 16, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2012
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)